Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage

被引:6
作者
Chen, Chuan-Shu [1 ,2 ]
Lin, Chia-Yen [1 ,2 ,3 ]
Wang, Chun-Li [4 ]
Wang, Shian-Shiang [1 ,2 ,5 ]
Li, Jian-Ri [2 ]
Yang, Chun-Kuang [2 ]
Cheng, Chen-Li [2 ]
Chiu, Kun-Yuan [2 ,5 ]
Yang, Shun-Fa [1 ,6 ]
机构
[1] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[2] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan
[3] Taichung Vet Gen Hosp, Div Surg Crit Care, Dept Crit Care Med, Taichung, Taiwan
[4] Taichung Vet Gen Hosp, Dept Family Med, Taichung, Taiwan
[5] Natl Chi Nan Univ, Dept Appl Chem, Nantou, Taiwan
[6] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan
关键词
Urothelial carcinoma; Upper tract; Node negative; Nephroureterectomy; Survival; Lymphovascular invasion; RADICAL NEPHROURETERECTOMY; PROGNOSTIC VALUE; ADJUVANT CHEMOTHERAPY; DISSECTION;
D O I
10.1016/j.urolonc.2020.08.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To evaluate the prognostic impact of lymphovascular invasion (LVI) on node-negative upper tract urothelial carcinoma (UTUC) in patients treated with radical nephroureterectomy (RNU). Materials and methods: A retrospective study was performed in single tertiary referral center of middle Taiwan between 2001 and 2015. Seven hundred and twenty-eight patients were diagnosed of UTUC and underwent RNU with ipsilateral bladder cuff excision including 303 and 195 patients with N0 and Nx status respectively. LVI status was assessed as a prognostic factor for cancer-specific (CSS) and overall survival (OS) using univariate and multivariate Cox regression analysis. Results: LVI was observed in 82 patients (16.5%). LVI presentation associated with smoking status, advanced tumor stage, high tumor grade, positive surgical margin, and consequence lung/liver/bone metastasis. In the multivariate analysis, LVI was failed to predict CSS, OS, and disease-free survival (DFS) (hazard ratio [HR] [95% confidence interval [CI]: 1.07 [0.55-2.09], 1.05 [0.62-1.79], 1.15 [0.69-1.92], in CSS, OS, DFS, respectively). In the subgroup analysis of pT1-2 disease, the CSS, OS, and DFS were associated with LVI status (HR [95% CI]: 2.29 [0.44-11.84], 3.17 [1.16-8.67], 2.66 [1.04-6.79], in CSS, OS, DFS, respectively). In contrast, there was no difference in pT3 disease. Conclusion: In conclusion, LVI status was not associated with survival outcomes of node-negative UTUC in our study. The subgroup analysis showed different prognostic impacts of LVI status in node-negative UTUC with T1-2 and T3 stage. Further evidence to clarify the prognostic effect is needed to make LVI became a practical factor in clinical decision-making. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:132.e13 / 132.e26
页数:14
相关论文
共 27 条
[1]   Results of POUT: A phase III randomised trial of perioperative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC). [J].
Birtle, Alison Jane ;
Chester, John David ;
Jones, Robert Jones ;
Johnson, Mark ;
Hill, Michaela ;
Bryan, Richard T. ;
Catto, James ;
Donovan, Jenny ;
French, Ann ;
Harris, Chris ;
Keeley, Francis ;
Kockelbergh, Roger ;
Powles, Thomas ;
Todd, Rachel ;
Tregellas, Lucy ;
Wilson, Caroline ;
Winterbottom, Andrew ;
Lewis, Rebecca ;
Hall, Emma .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
[2]   Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma [J].
Brien, James C. ;
Shariat, Shahrokh F. ;
Herman, Michael P. ;
Ng, Casey K. ;
Scherr, Douglas S. ;
Scoll, Benjamin ;
Uzzo, Robert G. ;
Wille, Mark ;
Eggener, Scott E. ;
Terrell, John D. ;
Lucas, Steven M. ;
Lotan, Yair ;
Boorjian, Stephen A. ;
Raman, Jay D. .
JOURNAL OF UROLOGY, 2010, 184 (01) :69-73
[3]   Influence of Positive Surgical Margin Status After Radical Nephroureterectomy on Upper Urinary Tract Urothelial Carcinoma Survival [J].
Colin, Pierre ;
Ouzzane, Adil ;
Yates, David R. ;
Francois, Audenet ;
Pignot, Geraldine ;
Arvin-Berod, Alexis ;
de Treigny, Olivier Merigot ;
Laurent, Guy ;
Valeri, Antoine ;
Jacques, Irani ;
Saint, Fabien ;
Gardic, Solene ;
Gres, Pascal ;
Rozet, Francois ;
Neuzillet, Yann ;
Ruffion, Alain ;
Roupret, Morgan .
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (11) :3613-3620
[4]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[5]   Adjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma: Results From the Upper Tract Urothelial Carcinoma Collaboration [J].
Hellenthal, Nicholas J. ;
Shariat, Shahrokh F. ;
Margulis, Vitaly ;
Karakiewicz, Pierre I. ;
Roscigno, Marco ;
Bolenz, Christian ;
Remzi, Mesut ;
Weizer, Alon ;
Zigeuner, Richard ;
Bensalah, Karim ;
Ng, Casey K. ;
Raman, Jay D. ;
Kikuchi, Eiji ;
Montorsi, Francesco ;
Oya, Mototsugu ;
Wood, Christopher G. ;
Fernandez, Mario ;
Evans, Christopher P. ;
Koppie, Theresa M. .
JOURNAL OF UROLOGY, 2009, 182 (03) :900-906
[6]   Comparison of Efficacy of Adjuvant MEC (Methotrexate, Epirubicin and Cisplatin) and GC (Gemcitabine and Cisplatin) in Advanced Upper Tract Urothelial Carcinoma [J].
Hung, Sheng-Chun ;
Wang, Shian-Shiang ;
Yang, Chun-Kuang ;
Li, Jian-Ri ;
Cheng, Chen-Li ;
Ou, Yen-Chuan ;
Ho, Hao-Chung ;
Chiu, Kun-Yuan ;
Chen, Chuan-Shu .
ANTICANCER RESEARCH, 2017, 37 (04) :1875-1883
[7]   Impact of lymphovascular invasion on oncological outcomes in patients with upper tract urothelial carcinoma after radical nephroureterectomy [J].
Hurel, Sophie ;
Roupret, Morgan ;
Ouzzane, Adil ;
Rozet, Francois ;
Xylinas, Evanguelos ;
Zerbib, Marc ;
Berod, Alexis Arvin ;
Ruffion, Alain ;
Adam, Emilie ;
Cussenot, Olivier ;
Houlgatte, Alain ;
Phe, Veronique ;
Nouhaud, Francois-Xavier ;
Bensadoun, Henri ;
Delage, Francky ;
Guillotreau, Julien ;
Guy, Laurent ;
Karsenty, Gilles ;
De La Taille, Alexandre ;
Colin, Pierre .
BJU INTERNATIONAL, 2013, 111 (08) :1199-1207
[8]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66
[9]   Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: Competing Risk Analysis after Propensity Score-Matching [J].
Kang, Minyong ;
Yoo, Heejin ;
Kim, Kyunga ;
Sung, Si Hyun ;
Jeon, Hwang Gyun ;
Park, Se Hoon ;
Seo, Seong Il ;
Jeon, Seong Soo ;
Lee, Hyun Moo ;
Choi, Han Yong ;
Jeong, Byong Chang .
JOURNAL OF CANCER, 2019, 10 (27) :6896-6902
[10]   Lymphovascular Invasion Predicts Clinical Outcomes in Patients With Node-Negative Upper Tract Urothelial Carcinoma [J].
Kikuchi, Eiji ;
Margulis, Vitaly ;
Karakiewicz, Pierre I. ;
Roscigno, Marco ;
Mikami, Shuji ;
Lotan, Yair ;
Remzi, Mesut ;
Bolenz, Christian ;
Langner, Cord ;
Weizer, Alon ;
Montorsi, Francesco ;
Bensalah, Karim ;
Koppie, Theresa M. ;
Fernandez, Mario I. ;
Raman, Jay D. ;
Kassouf, Wassim ;
Wood, Christopher G. ;
Suardi, Nazareno ;
Oya, Mototsugu ;
Shariat, Shahrokh F. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :612-618